当前位置:首页 - 行情中心 - 羚锐制药(600285) - 财务分析 - 现金流量表

羚锐制药

(600285)

  

流通市值:124.15亿  总市值:124.43亿
流通股本:5.66亿   总股本:5.67亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金3,065,164,136.212,035,553,754.08895,511,232.13,825,702,138.26
  收到的税费返还---761,756.01
  收到其他与经营活动有关的现金43,574,093.7633,866,1777,720,867.4598,371,818.02
  经营活动现金流入小计3,108,738,229.972,069,419,931.08903,232,099.553,924,835,712.29
  购买商品、接受劳务支付的现金474,324,248.33294,403,477.76172,076,316.72714,912,160.76
  支付给职工以及为职工支付的现金283,353,445.18185,738,783.0974,714,723.82367,554,981.62
  支付的各项税费389,371,771.63276,716,164.12137,138,823.49494,167,389.55
  支付其他与经营活动有关的现金1,471,301,108.47956,973,999.36401,686,335.41,472,336,947.23
  经营活动现金流出小计2,618,350,573.611,713,832,424.33785,616,199.433,048,971,479.16
  经营活动产生的现金流量净额490,387,656.36355,587,506.75117,615,900.12875,864,233.13
二、投资活动产生的现金流量:
  收回投资收到的现金23,941,820.1523,941,820.1523,352,833.0935,697,360.17
  取得投资收益收到的现金21,690,815.5716,374,701.6914,514,191.7920,161,914.21
  处置固定资产、无形资产和其他长期资产收回的现金净额7,185,4627,185,162323,00017,850
  处置子公司及其他营业单位收到的现金净额--822,114.54-
  收到的其他与投资活动有关的现金669,378,505.22146,500,000120,000,000410,000,000
  投资活动现金流入小计722,196,602.94194,001,683.84159,012,139.42465,877,124.38
  购建固定资产、无形资产和其他长期资产支付的现金38,225,885.1132,618,221.3511,743,474.69115,110,392.18
  投资支付的现金20,000,00020,000,000-10,000,000
  取得子公司及其他营业单位支付的现金672,549,843.75672,549,843.75672,549,843.75-
  支付其他与投资活动有关的现金1,185,703,151.68397,492,610260,492,6101,006,599,055.54
  投资活动现金流出小计1,916,478,880.541,122,660,675.1944,785,928.441,131,709,447.72
  投资活动产生的现金流量净额-1,194,282,277.6-928,658,991.26-785,773,789.02-665,832,323.34
三、筹资活动产生的现金流量:
  吸收投资收到的现金---35,141,322
  取得借款收到的现金517,374,558.27398,070,362.2911,340,271.8940,433,003.9
  收到其他与筹资活动有关的现金---8,619,222.74
  筹资活动现金流入小计517,374,558.27398,070,362.2911,340,271.8984,193,548.64
  偿还债务支付的现金70,000,00010,000,000-102,844,440.21
  分配股利、利润或偿付利息支付的现金510,338,609.65509,986,252.9414,611.12451,344,714.03
  支付其他与筹资活动有关的现金1,840,710.651,052,511.05202,9771,942,276.36
  筹资活动现金流出小计582,179,320.3521,038,763.95617,588.12556,131,430.6
  筹资活动产生的现金流量净额-64,804,762.03-122,968,401.6610,722,683.77-471,937,881.96
四、汇率变动对现金及现金等价物的影响-22,131.92-18,920.46-12,982.27,770.61
五、现金及现金等价物净增加额-768,721,515.19-696,058,806.63-657,448,187.33-261,898,201.56
  加:期初现金及现金等价物余额1,228,377,8061,228,377,8061,228,377,8061,490,276,007.56
  期末现金及现金等价物余额459,656,290.81532,318,999.37570,929,618.671,228,377,806
补充资料:
  净利润-475,868,499.88-722,584,691.99
  资产减值准备-35,682.24-501,754.11
  固定资产和投资性房地产折旧-33,229,438.81-60,753,162.81
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-33,229,438.81-60,753,162.81
  无形资产摊销-11,536,163.03-10,984,589.09
  长期待摊费用摊销-1,403,350.56-2,686,349.5
  处置固定资产、无形资产和其他长期资产的损失--4,703,827.72--12,061.9
  固定资产报废损失-93,037.72-3,911,232.06
  公允价值变动损失-1,998,717.96-10,490.56
  财务费用-1,608,648.59-661,121.11
  投资损失--24,131,253.21--40,214,203.52
  递延所得税--7,023,107.22--220,901.18
  其中:递延所得税资产减少--9,114,102.39--11,326,243.92
    递延所得税负债增加-2,090,995.17-11,105,342.74
  存货的减少-59,239,026.45-31,877,421.29
  经营性应收项目的减少--235,881,828.29-17,405,825.85
  经营性应付项目的增加-20,994,518.89-52,425,235.42
  其他-13,318,874.18-4,984,179.22
  现金的期末余额-532,318,999.37-1,228,377,806
  减:现金的期初余额-1,228,377,806-1,490,276,007.56
  现金及现金等价物的净增加额--696,058,806.63--261,898,201.56
公告日期2025-10-302025-08-202025-04-262025-04-26
审计意见(境内)标准无保留意见
TOP↑